[1]
“Simvastatin is effective in killing the radioresistant breast carcinoma cells”, Radiol Oncol, vol. 55, no. 3, pp. 305–316, Jul. 2021, Accessed: Aug. 03, 2026. Available: https://www.ojstest.computing.si/index.php/ro/article/view/3679